These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4761661)

  • 21. Immunization of turkey breeder hens against fowl cholera by combined oral and wing-web administration of attenuated (CU) pasteurella multocida.
    Ghazikhanian GY; Dungan WM; Kelly BJ
    Avian Dis; 1983; 27(1):133-40. PubMed ID: 6847537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterin-induced protection of turkeys against fowl cholera following infection with Bordetella avium.
    Rimler RB; Kunkle RA
    Avian Dis; 1998; 42(4):752-6. PubMed ID: 9876844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fowl cholera immunization in turkeys. II. Use of experimental epornitic method to study vaccine efficacy in flocks of turkeys.
    Dawe DL; Davis RB; Brown J; Foster JW; Srivastava KK
    Appl Microbiol; 1970 May; 19(5):842-3. PubMed ID: 5422311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of commercial and autogenous bacterins for control of the cranial form of fowl cholera in turkeys.
    Olson LD; McCune EL; Bond RE
    Avian Dis; 1969 May; 13(2):252-60. PubMed ID: 5816041
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of an enzyme-linked immunosorbent assay to measure antibody responses in turkeys against Pasteurella multocida.
    Marshall MS; Robison RA; Jensen MM
    Avian Dis; 1981; 25(4):964-71. PubMed ID: 7039594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on Pasteurella multocida. VI. Nature of systemic immunity and analysis of the correlation between levels of immunity induced by various fowl cholera vaccines and protection against challenge.
    Dua SK; Maheswaran SK
    Avian Dis; 1978; 22(4):748-64. PubMed ID: 749893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of isolates of Pasteurella multocida obtained on consecutive or different years from the same turkey farms.
    Donahue JM; Olson LD
    Avian Dis; 1972; 16(3):529-34. PubMed ID: 5038653
    [No Abstract]   [Full Text] [Related]  

  • 28. A bird-contact method of challenging turkeys with Pasteurella multocida.
    Alls AA; Appleton GS; Ipson JR
    Avian Dis; 1970 Feb; 14(1):172-8. PubMed ID: 5434435
    [No Abstract]   [Full Text] [Related]  

  • 29. Properties of free endotoxin from Pasteurella multocida.
    Heddleston KL; Rebers PA
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):573-4. PubMed ID: 1092224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenutated live fowl cholera vaccine. III. Laboratory and field vaccination trials in turkeys and chickens.
    Michael A; Geier E; Konshtok R; Hertman I; Markenson J
    Avian Dis; 1979; 23(4):878-85. PubMed ID: 546411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of two avirulent vaccines for preventing experimental fowl cholera in turkeys, and use of one vaccine in the field.
    Olson LD
    Avian Dis; 1977; 21(2):178-84. PubMed ID: 869825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible genetic variation in resistance of turkeys to erysipelas and fowl cholera.
    Saif YM; Nestor KE; Dearth RN; Renner PA
    Avian Dis; 1984; 28(3):770-3. PubMed ID: 6487197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic associations between fowl cholera and other diseases.
    Carpenter TE; Snipes KP; Hird DW; Hirsh DC
    Avian Dis; 1991; 35(4):718-22. PubMed ID: 1786004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The plasmacyte reaction and growth test in assessing immunity to fowl pasteurellosis].
    Butkin EI
    Veterinariia; 1968 Aug; 45(8):22-3. PubMed ID: 5736777
    [No Abstract]   [Full Text] [Related]  

  • 35. [Agglutination reaction in chickens immune and susceptible to P. multocida].
    Mateev M
    Vet Med Nauki; 1973; 10(7):9-17. PubMed ID: 4792316
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of protection against avian cholera by vaccination with recombinant P6-like protein from Pasteurella multocida.
    Kasten RW; Wakenell PS; Ahmad S; Yilma TD; Hirsh DC
    Avian Dis; 1997; 41(4):972-6. PubMed ID: 9454935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys.
    Hopkins BA; Olson LD
    Avian Dis; 1997; 41(2):317-25. PubMed ID: 9201394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fowl cholera immunization in turkeys. 3. Significance of market quality in the evaluation of fowl cholera vaccines.
    Davis RB; Brown J; Dawe DL; Foster JW; Srivastava KK
    Appl Microbiol; 1970 May; 19(5):844-7. PubMed ID: 5422312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between anti-Pasteurella multocida antibody titers after CU vaccination and survival after challenge.
    Schlink GT; Olson LD
    Avian Dis; 1989; 33(3):506-10. PubMed ID: 2775097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA, IgG, and anti-Pasteurella multocida antibody levels in bursectomized and/or cyclophosphamide-treated turkeys after CU vaccination.
    Schlink GT; Olson LD; Saif YM; Jackwood DJ
    Avian Dis; 1993; 37(3):668-72. PubMed ID: 8257356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.